1887
Volume 2022, Issue 4
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Introduction: The risk factors influencing the natural course of chronic kidney disease (CKD) are complex and heterogeneous. Recognizing the factors associated with CKD progression can enable the identification of high-risk patients for more intensive treatment.

Patients and methods: A retrospective evaluation of CKD patients was performed under follow-up between January 1, 2001 and December 31, 2016 at a tertiary health care center.

Results: Among 5370 screened patients, 1020 patients with complete data were included in the analysis. The median follow-up period for the studied patients was 9.3 years. Based on the analysis, 120 (11.8%) patients had reached end-stage kidney disease “ESKD” or death. The study revealed that the risk factors associated with reaching ESKD and/or death using Kaplan–Meier survival curve and log rank test included higher hemoglobin A1c among diabetic patients, higher grade of proteinuria, and non use of renin-angiotensin system blockers. The patients with CKD progression constituted 77.2% of all CKD patients. The study findings indicated that older age, Arab ethnicity, smoking habit, diabetes mellitus and hypertension (presumed as original kidney diseases) are among the significant risk factors associated with a further decline of the estimated glomerular filtration rate (eGFR) and further CKD progression.

Conclusion: This study summarized the demographic and clinical risk factors associated with CKD progression and patients’ outcomes among a unique and heterogeneous population in the state of Qatar. Intensive treatment of modifiable risk factors could be of value in halting the progression of CKD. However, prospective studies are warranted to confirm our findings.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2022.57
2022-11-30
2024-06-17
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2022/4/qmj.2022.57.html?itemId=/content/journals/10.5339/qmj.2022.57&mimeType=html&fmt=ahah

References

  1. Tsai WC, Wu HY, Peng YS, et al. Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis. Med (Baltim). 95:e3013;2016.
    [Google Scholar]
  2. Hounkpatin HO, Fraser SDS, Honney R, Dreyer G, Brettle A, Roderick PJ. Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a systematic scoping review. BMC Nephrol 21:217;2020.
    [Google Scholar]
  3. Renal Data System (USRDS) Annual Data Report. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008.
  4. Fischer MJ, Hsu JY, Lora CM et al. CKD Progression and mortality among hispanics and non-hispanics. J Am Soc Nephrol. 27:3488–3497;2016.
    [Google Scholar]
  5. Al Malki H., Rashed AH, Asim M. Renal replacement therapy in Qatar—past, present and future. Open J Nephrol. 8:42-55;2018.
    [Google Scholar]
  6. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). Ann Intern Med. 5;:150:604–612;2009.
    [Google Scholar]
  7. KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease Kidney Int Suppl 3:1–150;2013.
    [Google Scholar]
  8. Arora P, Jalal K, Gupta A, Carter RL, Lohr JW. Progression of kidney disease in elderly stage 3 and 4 chronic kidney disease patients. Int Urol Nephrol. 49:1033–1040;2017.
    [Google Scholar]
  9. Sesso R, Prado F, Vicioso B, Ramos LR. Prospective study of progression of kidney dysfunction in community-dwelling older adults. Nephrology (Carlton). 13:99–103;2008.
    [Google Scholar]
  10. Farag YMK, Kari JA, Singh AK. Chronic kidney disease in the Arab world: a call for action. Nephron Clin Pract 121:c120-c123;2012.
    [Google Scholar]
  11. Nazzal Z, Hamdan Z, Masri D, Abu-Kaf O, Hamad M. Prevalence and risk factors of chronic kidney disease among Palestinian type 2 diabetic patients: a cross-sectional study. BMC Nephrol 21:484;2020.
    [Google Scholar]
  12. Sangmi L, Shinchan K, Young S, et al. Smoking, smoking cessation, and progression of chronic kidney disease: results from KNOW-CKD Study. . Nicotine Tob Res. 23;2021.
    [Google Scholar]
  13. Tsai WC, Wu HY, Peng YS, Ko MJ, Wu MS, Hung KY, et al. Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis. Med (Baltim). 95:e3013;2016.
    [Google Scholar]
  14. Breyer JA, Bain RP, Evans JK, et al. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int. 50:1651-1658;1996.
    [Google Scholar]
  15. Gall MA, Hougaard P, Borch-Johnsen K, et al. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ. 314:783-788;1997.
    [Google Scholar]
  16. Holl RW, Grabert M, Thon A, Heinze E. Urinary excretion of albumin in adolescents with type 1 diabetes: persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control. Diabetes Care. 22:1555-1560;1999.
    [Google Scholar]
  17. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 358:2560-2572;2008.
    [Google Scholar]
  18. Lorenzo V, Saracho R, Zamora J, Rufino M, Torres A. Similar renal decline in diabetic and non-diabetic patients with comparable levels of albuminuria. Nephrol Dial Transplant. 25:835–841;2010.
    [Google Scholar]
  19. Van den Belt SM, Heerspink HJL, Gracchi V, de Zeeuw D, Wühl E, Schaefer F, ESCAPE Trial Group . Early proteinuria lowering by angiotensin-converting enzyme inhibition predicts renal survival in children with CKD. J Am Soc Nephrol. 29:2225–2233;2018.
    [Google Scholar]
  20. Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A metaanalysis of patient-level data. Ann Intern Med. 135:73–87;2001.
    [Google Scholar]
  21. Cabrera CS, Lee AS, Olsson M, Schnecke V, Westman K, Lind M, et al. Impact of CKD progression on cardiovascular disease risk in a contemporary UK cohort of individuals with diabetes. Kidney Int Rep. 5:1651–1660;2020.
    [Google Scholar]
  22. Turin TC, James M, Ravani P, Tonelli M, Manns BJ, Quinn R, et al. Proteinuria and rate of change in kidney function in a community-based population. J Am Soc Nephrol. 24:1661–1667;2013.
    [Google Scholar]
/content/journals/10.5339/qmj.2022.57
Loading
/content/journals/10.5339/qmj.2022.57
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): chronic kidney diseaseend-stage kidney disease and progression risk factors
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error